ARG1 and cancer: In neoplastic diseases, MDSCs are major contributors to the intra-tumoral arginase activity observed in both preclinical models and cancer patients [167, 174–176], in which tumor-derived factors, such as PGE2, can induce Arg1 expression via STAT3 or STAT6 [167, 177, 178].